National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01DC02	ZINNAT	B	Cefuroxime (axetil) - 250mg	250mg	Tablet, film coated	349,399 L.L
J01DC02	ZINNAT	B	Cefuroxime (axetil) - 250mg/5ml	250mg/5ml	Granules for suspension	1,120,782 L.L
J01DC02	ZINNAT	B	Cefuroxime (axetil) - 500mg	500mg	Tablet, film coated	908,603 L.L
J01DC02	ZINOXIMOR	G	Cefuroxime (axetil) - 500mg	500mg	Tablet, film coated	698,798 L.L
J01DC02	ZILISTEN	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	155,886 L.L
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 1%	1%	Drops	170,668 L.L
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 10mg	10mg	Tablet, film coated	593,978 L.L
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 5mg/5ml		Solution	278,175 L.L
A10BK01	ZYGLOR 10	G	Dapagliflozin - 10mg	10mg	Tablet, film coated	2,039,953 L.L
A10BD15	ZYGLOMET XR 10/1000	G	Dapagliflozin - 10mg, Metformin HCl XR - 1000mg		Tablet, film coated	2,467,295 L.L
A10BD15	ZYGLOMET XR 5/1000	G	Dapagliflozin - 5mg, Metformin HCl XR - 1000mg		Tablet, film coated	2,578,386 L.L
C08DB01	ZALDEM CR	G	Diltiazem HCl - 120mg	120mg	Capsule, controlled release	517,059 L.L
C08DB01	ZALDEM CR	G	Diltiazem HCl - 180mg	180mg	Capsule, controlled release	966,287 L.L
C08DB01	ZALDEM CR	G	Diltiazem HCl - 240mg	240mg	Capsule, controlled release	1,002,123 L.L
C08DB01	ZALDEM	G	Diltiazem HCl - 60mg	60mg	Tablet, scored	199,657 L.L
N06AB10	ZELAX 10	G	Escitalopram (oxalate) - 10mg	10mg	Caplet	833,182 L.L
N06AB10	ZELAX 20	G	Escitalopram (oxalate) - 20mg	20mg	Caplet	1,544,075 L.L
N03AF04	ZEBINIX	B	Eslicarbazepine acetate - 800mg	800mg	Tablet	11,123,961 L.L
C10AX09	ZEMIL	G	Ezetimibe - 10mg	10mg	Tablet	944,529 L.L
L03AA02	ZARZIO	BioTech	Filgrastim - 300mcg/0.5ml	30MU/0.5ml	Injectable solution	13,053,190 L.L
L03AA02	ZARZIO	BioTech	Filgrastim - 300mcg/0.5ml	30MU/0.5ml	Injectable solution	13,053,190 L.L
N07CA03	ZINASEN	G	Flunarizine (HCl) - 10mg	10mg	Tablet	599,354 L.L
D06AX01	ZETA	G	Fusidic acid - 20mg/g	20mg/g	Cream	178,731 L.L
D07CC01	ZETA-CORT	G	Fusidic acid - 20mg/g, Betamethasone (valerate) - 1mg/g		Cream	244,579 L.L
L02AE03	ZOLADEX LA	B	Goserelin (acetate) - 10.8mg	10.8mg	Injectable suspension	35,121,328 L.L
L02AE03	ZOLADEX LA	B	Goserelin (acetate) - 10.8mg	10.8mg	Injectable suspension	L.L
L02AE03	ZOLADEX DEPOT	B	Goserelin (acetate) - 3.6mg	3.6mg	Injectable suspension	8,820,074 L.L
L01DB06	ZAVEDOS	B	Idarubicin HCl - 10mg	10mg	Injectable freeze dried material	12,071,013 L.L
C09CA04	ZIOREL	G	Irbesartan - 150mg	150mg	Tablet, film coated	575,933 L.L
C09DA04	ZIOREL PLUS	G	Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	559,294 L.L